Accessibility Menu
NanoSphere Health Sciences logo

NanoSphere Health Sciences(OTC) NSHSF

Current Price$0.01
Market Cap$102.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-97%
1 Year+163%
1 Month+4%
NanoSphere Health Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.012026-07-01
NanoSphere Health Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.17%USD 0.012026-06-24
1 month+4.17%USD 0.012026-05-29
3 month+0%USD 0.012026-03-27
Year to date-24.24%USD 0.012025-12-29
1 year+163.16%USD 0.002025-06-25
3 year+100%USD 0.012023-06-28
5 year-97.06%USD 0.342021-06-28
Since inception-99.91%USD 10.932017-12-11

NanoSphere Health Sciences Financials at a Glance

Market Cap

$102.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$83.08K

EPS (TTM)

-$0.01

P/E Ratio

-1.23

Dividend

$0.00

Beta (Volatility)

3.11 (High)

Price

$0.01

Volume

100

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

N/A

NSHSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NanoSphere Health Sciences

NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, focusing on the delivery of biologically active compounds in the United States and Canada. The company’s flagship product, the NanoSphere Deliver System, utilizes advanced nanotechnology to enhance the absorption of supplements, nutraceuticals, and non-prescription drugs across various industries.

Products and Services
  • NanoSphere Deliver System for enhanced absorption of compounds
  • Applications in cannabis, pharmaceuticals, and animal health
  • Focus on biologically active compounds for diverse markets
Growth Outlook
  • Established in 2005, with a growing presence in biotechnology
  • Potential for expansion in the cannabis and nutraceutical markets
  • Innovative technology positions the company for future growth
Financial Highlights
  • Recent quarterly net income of $39,296, showing positive momentum
  • Trailing twelve months (TTM) revenue remains at $0, indicating growth potential
  • Cash and cash equivalents at $1,882, reflecting liquidity challenges
NanoSphere Health Sciences Inc. is positioned within the biotechnology sector, leveraging its innovative NanoSphere Deliver System to enhance the efficacy of various health products. The company has established a foundation for growth, particularly in the expanding cannabis and nutraceutical markets. Despite recent financial challenges, including a TTM revenue of $0, the recent quarterly net income indicates a potential turnaround. The liquidity position, with cash and cash equivalents at $1,882, highlights the need for strategic financial management. Investors may find interest in the company's unique technology and its applications across multiple industries, which could drive future growth.
AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Toby Lim

Website

www.nanospherehealth.com

Headquarters

Vancouver, BC V6E 3V7, CA

NSHSF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

6.14%

Return on Capital

N/A

Return on Assets

-494.03%

Earnings Yield

-81.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$102.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

10.28M

Volume

100

Avg. Volume

196.613

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$178.95K

EBITDA

-$131.01K

Operating Cash Flow

-$24.37K

Capital Expenditure

$0.00

Free Cash Flow

-$24.37K

Cash & ST Invst.

$1.88K

Total Debt

$57.14K

NanoSphere Health Sciences Performance Analysis

NanoSphere Health Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
NanoSphere Health Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31N/A
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
NanoSphere Health Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.03-47.6%
20232023-12-31USD -0.02-19.0%
20242024-12-31USD 0.03N/A
20252025-12-31USD -0.01N/A
NanoSphere Health Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-123.7%
Q22025-06-3084.0%
Q32025-09-30160.0%
Q42025-12-31333.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$102.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$34.27K

N/A

Employees

3

N/A

Net Income

$39.30K

-90.4%

EBITDA

-$49.71K

-112.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$1.88K

-6.9%

Total Debt

$57.14K

+86.1%

Accounts Receivable

$14.93K

+29.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$57.14K

+86.1%

Return on Assets

-4.94%

N/A

Return on Invested Capital

13.26%

N/A

Free Cash Flow

-$32.22K

-117.7%

Operating Cash Flow

-$32.22K

-117.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
THERTheralink Technologies, Inc.
$0.00+0.00%
BIXTBioxytran, Inc.
$0.02+0.10%
BVAXFBioVaxys Technology Corp.
$0.11+54.71%
CPMVMosaic ImmunoEngineering Inc.
$0.67+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLATesla
$320.21-0.14%
NVDANvidia
$208.75-0.02%
SMCISuper Micro Computer
$31.26+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%

Questions About NSHSF

What is the current price of NanoSphere Health Sciences?

NanoSphere Health Sciences is trading at $0.01 per share.

What is the 52-week range for NanoSphere Health Sciences?

Over the past 52 weeks, NanoSphere Health Sciences has traded between $0.00 and $0.02.

How much debt does NanoSphere Health Sciences have?

As of the most recent reporting period, NanoSphere Health Sciences reported total debt of $57.24K.

How much cash does NanoSphere Health Sciences have on hand?

NanoSphere Health Sciences reported $1.89K in cash and cash equivalents in its most recent financial results.

What is NanoSphere Health Sciences’s dividend yield?

NanoSphere Health Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services